Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Rapid Dose Therapeutics Corp. plans to issue common shares to its non-management directors as a means of settling $150,000 in director fees, aiming to improve its financial position by reducing liabilities. This shares-for-debt transaction will not create a new control person and complies with Canadian regulatory exemptions.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.